HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul D Eve Selected Research

Paul D Eve Research Topics

Disease

8Neoplasms (Cancer)
01/2016 - 06/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Neuroblastoma
10/2012
1Breast Neoplasms (Breast Cancer)
02/2011
1Glioblastoma (Glioblastoma Multiforme)
02/2011

Drug/Important Bio-Agent (IBA)

3GemcitabineFDA Link
01/2016 - 01/2010
23- ((1- (dimethylamino)propan- 2- yl)oxy)- 5- ((4- methoxy- 5- (1- methyl- 1H- pyrazol- 4- yl)pyridin- 2- yl)amino)pyrazine- 2- carbonitrileIBA
11/2012 - 10/2012
2Biomarkers (Surrogate Marker)IBA
10/2012 - 02/2011
1CCT245737IBA
01/2016
1Irinotecan (Camptosar)FDA LinkGeneric
10/2012
1AT13148IBA
07/2012
1Phosphotransferases (Kinase)IBA
07/2012
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
07/2012
1rho-Associated KinasesIBA
07/2012
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2012
14- (4- chlorobenzyl)- 1- (7H- pyrrolo(2,3- d)pyrimidin- 4- yl)piperidin- 4- amineIBA
02/2011
1Antineoplastic Agents (Antineoplastics)IBA
01/2010
1Drug CombinationsIBA
01/2010
1Etoposide (VP 16)FDA LinkGeneric
01/2010
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2010
1Cyclin-Dependent Kinase 4IBA
06/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2012 - 01/2010
1Oral Administration
10/2012
1Therapeutics
01/2011